Cases are identified through Houston Methodist’s virus genome sequencing program.
Through Dec. 12, the program found omicron cases accounted for 45 percent of all Houston Methodist COVID-19 infections, according to data sent to Becker’s Dec. 17. On Dec. 15, Houston Methodist said 32 percent of its symptomatic COVID-19 cases were from omicron.
In less than three weeks, omicron became the cause of the majority of new Houston Methodist cases, according to the most recent news release. In comparison, delta took about three months to surpass 80 percent of cases after initial detection.
According to S. Wesley Long, MD, PhD, medical director of diagnostic microbiology at Houston Methodist, omicron has a doubling time of 2.2 days.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
